Meta-analysis of 6 studies (5 RCTs, 1 case-matched; 293 patients on chemotherapy): oral mucositis in 46.1% with hangeshashinto vs 51.3% with none or placebo (RR 0.86, 95% CI 0.73–1.00, P=0.05); hangeshashinto may reduce risk, borderline significance.
Meta-analysisn = 293
Ishizuka et al. Hangeshashinto for the prevention of oral mucositis in patients receiving chemotherapy: a systematic review and meta-analysis